Jeffrey S. Nye, M.D., Ph.D.
Janssen Pharmaceutical Companies of Johnson & Johnson
Dr. Nye is responsible for external R&D in neuroscience, focusing on novel business relationships, venture, academic, public-private partnerships and risk-shared outsourcing. Previously, Dr. Nye was Chief Medical Officer of the East Coast Research and Early Development unit and was responsible for early programs across all therapeutic areas. Prior roles include Vice President of Experimental Medicine, and leader of programs for Galantamine for Alzheimer's disease, and Topamax for epilepsy and migraine. He previously served as a Director of CNS Discovery Genomics and Biotechnology at Pharmacia. Prior to joining the pharmaceutical industry, Dr. Nye was a tenured associate professor of Molecular Pharmacology, Biological Chemistry and Pediatrics (Neurology) at Northwestern University. He has a B.A. and M.A. from Harvard, and a M.D. and Ph.D. (with Solomon Snyder) from the Johns Hopkins University School of Medicine. He served as resident, postdoctoral fellow (with Richard Axel) and assistant professor of Pediatrics in Neurology at the College of Physicians and Surgeons of Columbia University. Dr. Nye has published over 60 papers on basic and clinical research, and has led pharma programs in discovery through clinical development. He has served on study sections and advisory panels, and currently serves as a Councilor of the British Association of Psychopharmacology and the co-chair of the New York Academy Alzheimer's Leadership council.